<DOC>
	<DOCNO>NCT01717690</DOCNO>
	<brief_summary>The purpose study determine whether daily bath 2 % chlorhexidine gluconate-impregnated antiseptic cleanser ( CHG ) significantly reduce incidence colonization hospitalize patient methicillin-resistant Staphylococcus aureus ( MRSA ) . Investigators postulate daily bath CHG significantly reduce incidence colonization hospitalize patient MRSA .</brief_summary>
	<brief_title>Study 2 % Chlorhexidine Gluconate-Impregnated Bath Cloths Prevent MRSA Colonization Complex Continuing Care</brief_title>
	<detailed_description>Bathing patient 2 % chlorhexidine gluconate-impregnated cloth ( CHG ) establish practice Baycrest . Our previous study demonstrate strong MRSA-preventive property CHG bath practice - rate MRSA transmission intervention unit drop 4.99 0.88 case per 1,000 patient day - overall rate reduction 82 % . Although CHG continue use part establish clinical practice hospital , impact MRSA prevention merit evaluation complex continue care ( CCC ) setting endemic MRSA . Investigators propose cluster-randomized , prospective , open-label , two-arm clinical trial ( RCT ) three geographically separate , otherwise comparable , CCC unit - one intervention unit use CHG , two control unit use non-antiseptic cleanser . The RCT expect conclusively answer whether daily bath CHG significantly reduce incidence MRSA colonization . By cluster randomization investigator imply randomly assign intervention three patient care unit . Investigators propose randomization unit feasible randomly assign individual participant intervention v control arm . For meaningful interpretation RCT finding , patient population three floor compare beginning , , end study . The following variable use compare patient population : - Colonization pressure ( CP ) measure MRSA reservoir unit . CP calculate onset RCT bi-weekly ( Number MRSA patient-days ร 100 รท Total Number Patient Days ) . - Average Braden scale score ( BSS ) patient unit measure predict pressure ulcer risk . It one measure patient 's clinical complexity . It calculate examine six patient criterion ( sensory perception , skin moisture , physical activity , mobility , nutrition , friction shear ) . BSS calculate onset RCT monthly . - Average Case Mix Index ( CMI ) value reflect daily relative weight resource use individual patient compare base resource level ( average resource use patient population ) . The CMI value dollar amount ; rather relative value indirect marker patient 's clinical complexity . CMI calculate onset RCT quarterly . Patient information de-identified privacy reason , analysis study data - logistic regression , compare rate MRSA incidence time MRSA conversion intervention control unit .</detailed_description>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<mesh_term>Anti-Infective Agents , Local</mesh_term>
	<criteria>MRSAnegative ( enrollment ) inpatient Complex Continuing Care program MRSApositive ( enrollment ) inpatient Complex Continuing Care program</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>MRSA</keyword>
	<keyword>chlorhexidine</keyword>
</DOC>